Zorex Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.74 M
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Satisfied Charges ₹ 3.15 Cr
- Revenue Growth 40.47%
- Profit Growth 761.12%
- Ebitda 47.16%
- Net Worth 8.88%
- Total Assets 42.55%
About Zorex Pharma
Zorex Pharma Private Limited (ZPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 May 1996 and has a history of 28 years and nine months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.74 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹3.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jigar Shah, Viral Shah, and Bhupendra Shah serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1996PTC029593
- Company No.
029593
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Zorex Pharma Private Limited offer?
Zorex Pharma Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Nutraceuticals & Dietary Supplements, Mineral Supplement, Cardiovascular Drugs & Medication, Antidiabetic Medicine, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Zorex Pharma?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jigar Shah ![]() | Director | 08-Feb-2010 | Current |
Viral Shah ![]() | Director | 08-Feb-2010 | Current |
Bhupendra Shah ![]() | Director | 09-Jan-1997 | Current |
Financial Performance of Zorex Pharma.
Zorex Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.47% increase. The company also saw a substantial improvement in profitability, with a 761.12% increase in profit. The company's net worth moved up by a moderate rise of 8.88%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Zorex Pharma?
Unlock access to Zorex Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹4.00 M
₹31.45 M
Charges Breakdown by Lending Institutions
- The Kalupur Commercial Co-Operative Bank Limited : 0.40 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
02 Sep 2022 | The Kalupur Commercial Co-Operative Bank Limited | ₹4.00 M | Open |
22 Apr 2013 | The Kaluput Commercial Co Op Bank Ltd | ₹6.95 M | Satisfied |
23 Apr 2010 | The Kalupur Commercial Co. Op. Bank Ltd. | ₹2.00 M | Satisfied |
13 Aug 2007 | The Kalupur Commercial Co-Op Bank Ltd. | ₹8.40 M | Satisfied |
07 Aug 2007 | The Kalupur Commercial Co.Op. Bank Ltd. | ₹2.00 M | Satisfied |
How Many Employees Work at Zorex Pharma?
Unlock and access historical data on people associated with Zorex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Zorex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zorex Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.